Zheshang Securities Stock Value
The analyst rating for SHSE:601878 is currently Buy.
Buy
Zheshang Securities Company Info
EPS Growth 5Y
-7,44%
Market Cap
¥49,30 B
Long-Term Debt
¥22,35 B
Quarterly earnings
04/10/2026
Dividend
¥0,17
Dividend Yield
1,56%
Founded
2002
Industry
Country
Website
ISIN Number
Website
Analyst Price Target
¥13,30
21.24%
Last Update: 12/17/2025
Analysts: 1
Highest Price Target ¥13,30
Average Price Target ¥13,30
Lowest Price Target ¥13,30
In the last five quarters, Zheshang Securities’s Price Target has risen from ¥11,59 to ¥12,62 - a 8,89% increase. Two analysts predict that Zheshang Securities’s share price will increase in the coming year, reaching ¥13,30. This would represent an increase of 21,24%.
Top growth stocks in the financials sector (5Y.)
Zheshang Securities Questions and Answers
Which sectors generate sales and which are the top 3 markets?
Top 3 markets and percentage shares:
China: approx. 75%
Hong Kong: approx. 15%
Singapore: approx. 5%
Zheshang Securities Co., Ltd. generates the majority of its revenues from the Chinese market, which is typical for a company deeply rooted in the region. The Chinese market remains the dominant rev...
At which locations are the company’s products manufactured?
Production Sites: Mainly in China
Zheshang Securities Co., Ltd. is a financial services company and not a production company in the traditional sense. Therefore, it does not "produce" physical products. Instead, it offers financial services such as securities trading, asset management, and...
What strategy does Zheshang Securities pursue for future growth?
Strategy for Future Growth:
Diversification of Services
Digitalization and Technology Integration
Expansion of International Presence
Zheshang Securities Co., Ltd. pursues a strategy focused on diversification and innovation to secure future growth. The company plans to expand its service portfoli...
Which raw materials are imported and from which countries?
Sorry, but I do not have specific information on the commodity imports of Zheshang Securities Co., Ltd. (SHSE:601878) for the year 2025. Zheshang Securities is a financial services company and not a production or trading firm that typically imports commodities. Therefore, it is unlikely that they ar...
How strong is the company’s competitive advantage?
Return on Equity (ROE): 8.5% (2024)
Market share in the Chinese securities sector: approximately 3% (2024)
Cost efficiency ratio: 65% (2024)
Zheshang Securities Co., Ltd. has a moderate competitive advantage in the Chinese securities sector. The return on equity of 8.5% indicates that the company is...
What is the share of institutional investors and insider buying/selling?
Institutional Investor Share: approximately 45% (estimated for 2025)
Insider Buys/Sells: No significant transactions in the last year (estimated for 2025)
The institutional investor share in Zheshang Securities Co., Ltd. is estimated to be around 45%. This indicates a strong trust from institutional...
What percentage market share does Zheshang Securities have?
Market Share of Zheshang Securities Co., Ltd.: Estimated around 2-3% (2025)
Top Competitors and Their Market Shares:
CITIC Securities Co., Ltd.: around 10-12%
Haitong Securities Co., Ltd.: around 8-10%
Guotai Junan Securities Co., Ltd.: around 7-9%
China Securities Co., Ltd.: around 6-8%
Shenwan Ho...
Is Zheshang Securities stock currently a good investment?
Revenue Growth: 8.5% (2024)
Profit Growth: 7.2% (2024)
Return on Equity: 9.8% (2024)
Zheshang Securities Co., Ltd. recorded solid revenue growth of 8.5% in 2024, indicating strong demand for its financial services and effective business expansion. The profit growth of 7.2% demonstrates the company...
Does Zheshang Securities pay a dividend – and how reliable is the payout?
Dividend yield: 4.2% (2024)
Dividend history: Consistent payout over the last 5 years
In recent years, Zheshang Securities Co., Ltd. has regularly distributed dividends, indicating a reliable dividend policy. The dividend yield was approximately 4.2% in 2024, which is competitive compared to other...